Advancing Thalassaemia and Sickle Cell Care Through Nordic Collaboration – TIF
Thalassaemia International Federation (TIF) shared a post on LinkedIn:
“Congratulations to Dr. Aba Sarr and Dr. Marte Holmboe Berg on completing TIF’s inaugural Henrik Birgens Fellowship!
From 21–25 September 2026, the two physicians from Norway joined the Danish Red Blood Cell Centre at Copenhagen University Hospital for an intensive programme exploring care for people living with thalassaemia and sickle cell disease.
Their learning took them through adult and paediatric clinics, laboratory services and multidisciplinary discussions, alongside specialists sharing their experience of everyday.
The fellows’ feedback highlighted key priorities: closer collaboration between paediatric and adult teams, better support as patients move between services, and stronger professional connections across the Nordic region.
Our warmest thanks to Dr. Andreas Glenthøj, Dr. Marianne Hoffmann, and the entire host team for their expertise and generous welcome, and to our first fellows for their enthusiasm and commitment.
Read the full fellowship completion report on our website.”
Stay updated with Hemostasis Today.
-
Oct 20, 2026, 14:01Ashkan Forouzani։ Warfarin or DOACs in Protein C and S Deficiency?
-
Oct 20, 2026, 13:20The Global Blood Crisis – Are We Solving the Wrong Problem?
-
Oct 20, 2026, 06:45Grant Garcia: Why Does a Blood Clot Diagnosis Immediately End an Athlete’s Season?
-
Oct 20, 2026, 06:35Parag Tamhankar: Landmark Study Reveals Genetic Spectrum and Targeted Therapies for ALPS in the Indian Population
-
Oct 20, 2026, 06:26Nina Houben: Neonatal Blood Transfusion Symposium and PhD Defense
-
Oct 20, 2026, 05:46Jan T. Kielstein: DNP Poisoning and Hemoadsorption The Limits of Rescue Therapy
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy